While reporting financial results for the third quarter on Wednesday, medical firm Zimmer Biomet Holdings Inc. (ZBH) reaffirmed its adjusted earnings and revenue growth guidance for the full-year 2025.For fiscal 2025, the company now projects adjusted earnings in a range of $8.10 to$8.30 per share on revenue growth of 6.7 to 7.7 percent from last year on a reported basis, with constant currency revenue growth of 6.2 to 6.7 percent and organic constant currency revenue growth of 3.5 to 4.0 percent.Previous ...